Gold prices slip lower; consolidating after recent gains
Eric Venker, President and COO of Roivant Sciences Ltd. (NASDAQ:ROIV), has recently sold a significant portion of his holdings in the company. According to a recent SEC filing, Venker sold 435,425 common shares in two separate transactions on February 12 and February 13, 2025. The shares were sold at a weighted average price range of $10.42 to $10.53, generating a total of approximately $4.56 million. The transaction occurred near the current market price of $10.56, with analysts setting price targets between $12 and $18. InvestingPro analysis shows the company maintains a strong balance sheet with more cash than debt and an impressive current ratio of 37.91.
In addition to the sales, Venker also exercised stock options to acquire 600,000 common shares at a price of $3.85 per share, which amounted to a total acquisition value of $2.31 million. These transactions reflect Venker's ongoing management of his equity position in Roivant Sciences.
As of the filing date, Venker holds 896,869 shares of Roivant Sciences following these transactions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.